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Abstract: The aim of this study was to analyze the relationship between the qualitative abnormalities
on nailfold videocapillaroscopy (NVC), and the concentrations of selected biomarkers (sE-selectin,
endothelin-1, high-sensitivity c-reactive protein (hsCRP)) and lipid metabolism parameters in
children and adolescents with Raynaud’s phenomenon (RP). Raynaud’s phenomenon, to assess
whether nailfold capillary changes may reflect the degree of systemic blood vessel abnormalities.
The study group included 66 patients (34 undifferentiated—uRP and 32 secondary—sRP) aged
6–19 years and the control group. In both groups, NVC was performed and the selected biomarkers
were measured (sE-selectin, endothelin-1, hsCRP) and lipid profile. Endothelin-1, sE-selectin and
hsCRP concentrations in patients from both RP groups were significantly higher; concentration of
HDL fraction was significantly lower compared with the control group. The analysis of multiple
linear regression demonstrated that megacapillaries most strongly determine the sE-selectin value
(p = 0.04) and hsCRP (p = 0.03). Both the total cholesterol and low-density lipoprotein (LDL) fraction
concentrations were determined by the presence of avascular areas (p = 0.02). In conclusion, specific
pathologic NVC changes were associated with higher endothelial damage biomarkers concentration
and adverse changes in the lipid profile.
Keywords: Raynaud’s phenomenon; videocapillaroscopy; biomarkers; lipid profile; endothelin
dysfunction; children; adolescents; atherosclerosis
1. Introduction
Microcirculation is an important, although still relatively insufficiently known component of the
cardiovascular system, both in a structural and functional respect [1–3].
Clinical manifestation of peripheral microcirculation disorders is a Raynaud’s phenomenon (RP),
which may precede autoimmune connective tissue diseases (CTDs) many years, or accompany them [4].
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RP consists of three phases, namely the ischemic phase, cyanotic phase and erythema phase.
The vasoconstriction of pre-capillary sphincters of the digital arteries and arterioles induced by cold
and/or emotional stress determines the initial marked pallor (ischemic phase); then pre-capillary
sphincters relax due to hypoxia and accumulation of anaerobic products, determining a hyper-flow of
blood in ischemic areas, with a rapid hemoglobin desaturation (cyanotic phase); finally, a pre and a
post-capillary sphincter dilatation induces a reactive, often painful, hyperemia (erythema phase).
An established method for the evaluation of structural abnormalities of the microcirculation is
the nailfold videocapillaroscopy (NVC). The videocapillaroscopic examination is non-invasive and
inexpensive, thus allowing multiple re-testing. Meanwhile, the computerized analysis of images of
the microcirculation and the possibility of data storage enable assessment of the dynamics of changes
taking place over time [5–7].
While capillaroscopic vascular assessment can be carried out at many points in the human
body, the most common studies are the microcirculation of the nailfold-nailfold videocapillaroscopy.
This method informs the researcher about the blood supply of tissues (shape, size, number and
filling of capillaries) and the degree of nourishment of the skin (background image or fields with no
blood vessels)
NVC is also a safe tool to examine the microcirculation in children and adolescents with CTDs.
NVC in rheumatologists’ practice has a dual use. First, it has a role in the differential diagnosis of
patients with RP. Second, it may have a role in the prediction of clinical complications in CTDs [8].
Furthermore, some researchers suggest that local microangiopathy found on NVC in RP patients
with/without CTDs also reflect disorders in the systemic microcirculation, including cardiovascular,
pulmonary or cerebral microcirculation [9–11].
The monitoring of morphological abnormalities in capillary vessels using NVC, particularly in
patients with long-standing Raynaud’s phenomenon, may also provide an indirect indication of the
presence of activation and/or dysfunction endothelial within the vessels of the microcirculation [12,13].
Hence, 2 hypotheses seemed worth checking out. First of all, the structural microcirculation
abnormalities found in NVC may be the symptoms of subclinical vasculitis in the course of RP. Secondly,
that NVC in combination with endothelial biomarkers may be a useful diagnostic tool to identify
preclinical prognosticators of endothelial dysfunction.
Endothelial dysfunction is the main trigger for the release of endothelin-1. Endothelin-1 is the
strongest vasoconstrictor, and in the RP, its release may stimulate, among others, low temperature,
shear stress or hypoxia [14]. In the pathomechanism of the RP, the role of ET-1 is still controversial,
although many researchers suggest that its increase in serum in patients with RP primarily indicates
the degree of damage to the vascular endothelium [15,16].
Like ET-1, E-selectin is specific for endothelial cells and only produced by them in contrast to
other adhesion molecules [12,17]. E-selectin at the early stage of endothelial activation mediates
the adhesion of neutrophils, monocytes, and T lymphocytes to the vascular wall, which may be
associated with increased permeability and subclinical vasculitis [18]. Hebbar et al. found increased
expression of E-selectin on endothelial cells in patients with Raynaud’s syndrome, who were followed
by systemic sclerosis (SSc) development [19]. The literature emphasizes that low-density lipoprotein
(LDL), after oxygenation, has an adverse effect on vasodilatation of vessels by stimulating the secretion
of ET-1. It is also suggested that HDL cholesterol inhibits the expression of E-selectin and mediating of
monocytes. What is more, long-lasting endothelial activation increases the passage of lipoproteins into
the endothelial space, their retention, and modification [20,21].
The importance of the release of the biochemical markers of endothelial damage in patients
with many years of Raynaud’s phenomenon history and capillaroscopic signs of microangiopathy
can be considered in the context of preterm preclinical atherosclerosis [8]. The studies on the adult
population of patients with CTD with or without RP unequivocally demonstrate an increased risk of
cardiovascular disease, as compared with the healthy population [22,23]. Many researchers suggest
that high-sensitivity c-reactive protein (hsCRP) is a putative marker of inflammation associated with
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atherosclerosis at its preclinical stage, stronger, and perhaps even more objective than the classic lipid
parameters [24,25].
Few published biophysical and biochemical studies on microcirculation damage in patients with
juvenile autoimmune diseases are available and they mainly concern patients with juvenile idiopathic
arthritis (JIA) [25]. Even less information assessing the possible relationship between capillaroscopic
changes in microcirculation and endothelial activation markers in juvenile Raynaud’s syndrome
without CTD manifestations is available [26].
It seems, therefore, a reasonable attempt to assess the usefulness of NVC in young patients with
RP, on the one hand, to assess the qualitative abnormalities in the nailfold videocapillaroscopy to
monitor the course of RP, and on the other, the analysis of the relationship between structural changes
in NVC and the concentration of endothelial damage biomarkers (sE-selectin, endothelin-1), lipid
fractions and hsCRP in children and adolescents with the Raynaud phenomenon in the aspect of the
risk assessment of subclinical vasculitis with possible inflammatory endothelial dysfunction.
2. Patients and Methods
2.1. Patients
Patients with Raynaud’s phenomenon (RP), treated at the Rheumatology Outpatient Clinic,
University Paediatric Teaching Hospital, in whom NVC was routinely performed, served as the basis
for selection of the study group. The degree of abnormalities on NVC, clinical assessment, RP history,
and serological status enabled distinguishing between two RP subtypes:
Undifferentiated RP (uRP): 34 patients with nonspecific NVC changes and without signs of
systemic connective tissue disease (CTD) [5,27].
Secondary RP (sRP): 32 patients with specific pathological NVC changes and diagnosed CTD or
incomplete diagnosis—undifferentiated connective tissue diseases (UCTDs) [28,29].
In all, the study group included 66 patients (42 girls and 24 boys) aged 6–19 years (mean age
14.5 ± 4.52).
Patients were divided into 2 groups. Group I: uRP-34 patients (mean age 13.07 ± 3.85), among
them 25 (76.4%) females and 9 (23.6%) males. II group (sRP) consisted of 32 patients (mean age
15.29 ± 4.52), 20 (65.7%) females and 12 (34.3%) males.
The mean duration of Raynaud’s phenomenon was 4.82 ± 3.21 years.
The control group included 20 healthy children matched for age and gender: (mean age 14.73 ± 3.10),
15 girls (75%) and 5 boys (25%) coming for control visits to the Rheumatology Outpatient Clinic,
without any cardiovascular burden and after ruling out infection on the basis of medical examination.
2.2. Methods
2.2.1. Nailfold Capillaroscopy
All the patients had a nailfold capillaroscopy with the use of a ZEISS STEMI 2000 capillaroscope.
An optical microscope was connected to a color digital camera and a personal computer.
The images taken during the examination were recorded on the computer’s hard disc drive (HDD)
and analyzed by the same experienced investigator, pediatric rheumatologist (AG).
The second investigator (MB) performed measurements of the number of capillaries on the
capillaroscopic images recorded on computer’s HDD by means of the NIS-ELEMENTS D2.30 computer
program, Nikon Corporation, Tokyo, Japan.
The second experimenter was blinded to the children’s condition
The nailfold videocapillaroscopy (NVC) examinations were performed after at least 20 min. of
acclimatization in a room with a constant temperature of 20–22 ◦C. Onto the examined finger cedar oil
was applied to ensure better light penetration. The light was shed at an angle of 45◦ from a ZEISS KLD
1500 LCD lamp.
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2.2.2. Qualitative Measurements
The structure of the capillaries was assessed by examination of the nailfold bed capillaries in 200×
magnification in all fingers of both hands (except thumbs). The capillary patterns were described as:
• non-specific pattern with a presence in at least two fingers: meandering and crossed capillaries,
non-homogeneous distribution or size of loops (irregular arrangement), focal distribution of
capillary hemorrhages, capillary spasm, widening of the afferent, apical and efferent parts of a
loop, prominent subpapillary plexus [27].
• specific pathological (scleroderma pattern) with a presence of giant capillaries (3–4 times wider
than the neighboring ones), frequent capillary hemorrhages, loss of capillaries (decrease of the
capillary density <6 capillaries/linear mm), mild disorganization of the capillary architecture,
the presence of avascular areas [29].
The number of tortuous and irregular vascular loops above two per one finger were regarded as
an abnormal pattern.
Exemplary capillaroscopic patterns are shown in Figures 1–3.
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2.2.3. Analytical Methods
The blood f r analysis wa collected on an empty stomach, during a control visit o the Rheumatology
Outpati nt Clinic or during hosp talizatio . The sera obtained after centrifuga ion were stored at a
temperature of −80 ◦C:
• sE-selectin concentration was determined by the ELISA immunoenzymatic test method, using
R&D Systems Quantikine kit, according to the test manufacturer’s instructions. The intensity of
the color reaction was determined at 450 nm wavelength. The test sensitivity was 0.027 ng/mL;
• endotheli -1 concentrations wer determined by the ELISA method, using a kit produced by IBL
International. The d gree of stai ing was measured at 450 m wavelength and was proportional
to serum ET-1 concentration. The measurement range was from 0.78 to 100 pg/mL and the test
sensitivity was 0.23 pg/mL;
• hsCRP concentration was determined by the immunoturbidimetric method with Roche Tina-quant
CRP HS reagent, using HITACHI 912 biochemical analyzer. The normal range was 0–0.5 mg/dL.
Lipid profile was determined by the enzymatic method using ready-to-use kits (Cormay, Poland).
The biochemical tests were performed at the Division of Paediatric Laboratory Diagnostics, University
Paediatric Teaching Hospital.
J. Clin. Med. 2019, 8, 567 6 of 17
2.2.4. The Statistical Analysis
The statistical analysis started with a material and logical review of collected data. In the first
stage, conformity and distribution of the studied continuous variables were verified against the
Gauss distribution. The hypothesis on the normality of the distribution was discarded. For this
reason, the non-parametric U Mann–Whitney test was used in the analyses (two compared groups).
For comparison of three or more independent groups, Kruskal–Wallis test which is comparable to
one-way ANOVA is used. The relationships between qualitative variables were evaluated with the
chi-squared test. The relationship between two quantitative variables was analyzed using multiple
linear regression models. The assumed statistical confidence level was p < 0.05. The statistical analysis
was performed using the STATA/1.C 12.1 application manufactured by StataCorp LP, College Station,
TX, USA.
2.2.5. Ethical Issues
The study was approved by the local Bioethics Committee of the Medical University of Bialystok,
nr R-I-002/136/2015.
3. Results
Secondary RP (sRP) was diagnosed in 32 (47.15%) of the studied subjects (9–localized scleroderma-
morphea or linear), 5–limited systemic sclerosis, 4–juvenile idiopathic arthritis, 3–juvenile dermatomyositis,
11–UCTDs. The remaining 34 (52.85%) patients were diagnosed with undifferentiated RP.
3.1. Analysis of Capillaroscopic Parameters
Qualitative analysis of capillary parameters in the group of patients with RP and in the control
group is shown in Table 1.
Table 1. Qualitative capillary parameters in the group of patients with Raynaud’s phenomenon (RP)
and in the control group.
Capillary Parameters
Group with RP
n = 66
Control Group
n = 20 Chi-Square Test
n % n %
Reduced number of
capillaries (≤6/mm linear) 16 24.24 0 0.00 p = 0.015
Irregular arrangement 40 66.67 0 0.00 p < 0.001
Tortuous capillaries 23 34.85 7 35.00 NS
Meandering capillaries 33 50.00 4 20.00 p = 0.018
Avascular areas 11 16.67 0 0.00 NS
Giant capillaries 36 54.55 0 0.00 p = 0.008
Hemorrhages 13 19.70 0 0.00 p = 0.031
Spastic loops 16 24.24 5 25.00 NS
Neoangiogenesis 5 7.58 0 0.00 p = 0.205
Bold: p < 0.05.
Analysis of qualitative capillary parameters in the group of patients with RP in relation to gender
showed a significantly more frequent presence of meandering capillaries and giant capillaries among
girls, p = 0.017 and p = 0.018, respectively; while the presence of neoangiogenesis was significantly
more frequent in boys: p < 0.001. The results are shown in Table 2.
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Table 2. Qualitative capillary parameters in the group of patients with RP in relation to gender.
Capillaroscopic Parameters
Male
n = 21
Female
n = 45 Ch-Square Test
n % n %
Reduced number of capillaries (<6/mm) 4 19.08 12 18.18 NS
Irregular arrangement 11 52.38 29 64.44 NS
Tortuous capillaries 6 28.57 17 37.78 NS
Meandering capillaries 6 28.57 27 60.00 p = 0.017
Avascular areas 4 19.05 7 15.56 NS
Giant capillaries 7 33.33 29 64.44 p = 0.018
Microhemorrhages 5 23.81 8 17.78 NS
Spastic loops 5 23.81 11 24.44 NS
Neoangiogenesis 3 10.90 2 4.28 p < 0.001
Bold: p < 0.05.
Analysis of qualitative capillary parameters in the group of patients with RP in relation to age
showed a significantly more frequent presence irregular arrangement, tortuous capillaries, meandering
capillaries and giant capillaries in the group of patients over 15 y.o. p = 0.017 i p = 0.018, p = 0.005 i
p = 0.011, respectively. The results are presented in Table 3.
Table 3. Qualitative capillary parameters in the group of patients with RP in relation to age.
Capillaroscopic Parameters
Age ≤ 15 Years
n = 13
Age >15 Years
n = 53 Chi-Square Test
n % n %
Reduced number of capillaries (<6/mm) 3 23.08 13 24.53 NS
Irregular arrangement 4 30.77 36 67.92 p =0.014
Tortuous capillaries 1 7.70 22 41.51 p = 0.022
Meandering capillaries 2 15.38 31 58.49 p = 0.005
Avascular areas 3 23.08 8 15.09 NS
Giant capillaries 3 23.08 33 62.26 p = 0.011
Microhemorrhages 4 30.77 9 16.98 NS
Spastic loops 4 30.77 12 22.64 NS
Neoangiogenesis 1 7.70 4 7.55 NS
Bold: p < 0.05.
The statistically significant differences between group with sRP and in the control group were
found concerning reduced density of capillaries (p = 0.002), irregular arrangement (p < 0.001),
number of meandering capillaries (p = 0.03), presence of giant capillaries (megacapillaries) (p < 0.001),
microhemorrhages (p = 0.015) and avascular areas (p < 0.003) (Table 4).
Table 4. Assessment of the qualitative capillaroscopic parameters in children and adolescents with
secondary Raynaud’s phenomenon (sRP) compared with the control group.
Capillaroscopic Parameters
Group with sRP
n = 32
Control Group
n = 20 Chi-Square Test
n % n %
Reduced number of capillaries (≤6/mm) 12 37.50 0 0.00 p = 0.002
Irregular arrangement 22 67.58 0 0.00 p < 0.001
Tortuous capillaries 12 37.50 7 35.00 NS
Meandering capillaries 12 37.50 2 10 p = 0.030
Giant capillaries 17 53.13 0 0.00 p < 0.001
Microhemorrhages 8 25.00 0 0.00 p = 0.015
Avascular areas 11 34.38 0 0.00 p = 0.003
Spastic loops 9 24.24 5 25.00 NS
Neoangiogenesis 3 9.38 0 0.00 NS
Bold: p < 0.05.
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In the group of patients with uRP, significant differences compared to the control group were
found only in the presence of irregular arrangement (p < 0.0001) and presence of megacapillaries
(p < 0.001). No significant differences between the uRP group and the control group in respect of
the number of tortuous capillaries and spastic capillaries were found. It should be stressed that no
megacapillaries and avascular areas were detected in the control group (Table 5).
Table 5. Assessment of the qualitative capillaroscopic parameters in children and adolescents with
undifferentiated Raynaud’s phenomenon (uRP) compared with the control group.
Capillaroscopic
Parameters
Group with uRP
n = 34
Control Group
n = 20 Chi-Square Test
n % n %
Reduced number of
capillaries (≤6/mm) 4 11.76 0 0.00 NS
Irregular arrangement 18 52.94 0 0.00 p < 0001
Tortuous capillaries 11 32.35 7 35.00 NS
Meandering capillaries 10 29.41 3 15.00 NS
Avascular areas 0 0.00 0 0.00 -
Giant capillaries 19 55.88 0 0.00 p < 0.001
Microhemorrhages 5 14.71 0 0.00 NS
Spastic loops 7 20.59 5 25.00 NS
Neoangiogenesis 2 5.88 0 0.00 NS
Bold: p < 0.05.
3.2. Analysis of Biochemical Tests
The clinical and biochemical parameters in the studied subjects with undifferentiated and
secondary Raynaud’s phenomenon and in the control group are shown in Table 6.
Table 6. Concentrations of the selected endothelial dysfunction markers and lipid metabolism
parameters in the patients with undifferentiated (uRP) and secondary Raynaud’s phenomenon (sRP)
compared with the control group.
Feature/Parameter Group with uRP(n = 34) Mean ± SD
Group with sRP
(n = 32) Mean ± SD
Control Group
(n = 20) Mean ± SD
ANOVA
Kruskal-Wallis Test
Age, years 13.07 ± 3.85 15.29 ± 4.52 14.73 ± 3.10 NS
RP duration, years 4.63 ± 2.34 5.74 ± 4.25 - NS
hsCRP, mg/dL 0.42 ± 0.43 0.59 ± 0.51 0.078 ± 0.03 p < 0.001
Endothelin-1, pg/mL 4.67 ± 3.38 5.74 ± 3,74 2.14 ± 0.6 p = 0.0134
sE-selectin, ng/mL 39.06 ± 10.98 47.51 ± 16.96 20.92 ± 5.87 p < 0.001
Total cholesterol,
mg/dL 159.62 ± 25.17 163.25 ± 27.12 143.4 ± 20.58 NS
TG, mg/dL 70.29 ± 25.52 73.19 ± 40.31 83.2 ± 22.95 NS
LDL, mg/dL 85.11 ± 20.55 85.13 ± 21.02 81.52 ± 17.25 NS
HDL, mg/dL 60.41 ± 14.15 63.66 ± 15.52 78.54 ± 18.35 p = 0.001
Bold: p < 0.05.
The mean duration of Raynaud’s phenomenon was not different between the URP and SRP groups.
A statistically significantly higher hsCRP concentration was demonstrated in URP and SRP patients
compared with the control group (p < 0.001). The concentrations of endothelin-1 and sE-selectin
in patients in both groups were significantly higher compared with the control group (p = 0.0134,
p < 0.001, respectively) (Table 6).
Analysis of biochemical parameters in relation to gender revealed significantly elevated levels
of LDL and sE-selectin in boys, p = 0.018, 0.011, respectively; while in girls significantly higher
concentrations of hsCRP (p = 0.017) were present. However, depending on the age, significantly higher
concentrations of LDL, TG, hsCRP, ET-1 in the group of older / over 15 years / respectively were found:
p = 0.002, p = 0.022, p = 0.030 and p = 0.016. In contrast, HDL concentration in the group above 15 years
was significantly lower (p < 0.001) (Tables 7 and 8).
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Table 7. Concentrations of the selected endothelial dysfunction markers and lipid metabolism
parameters in the patients with RP in relation to gender.
Biochemical Parameters
Male
n = 21
Female
n = 45 Chi-Square Test
n % n %
Total cholesterol > 180 mg/dL 1 4.76 7 15.56 NS
LDL cholesterol > 115 mg/dL 14 66.67 16 35.56 p = 0.018
HDL cholesterol ≤ 48 mg/dL 15 71.43 27 60.00 NS
Triglicerides > 110 mg/dL 5 23.81 18 40.00 NS
hsCRP ≥ 0.5 mg/dL 6 28.57 27 60.00 p = 0.017
sEselectin ≥ 40 ng/mL 15 71.43 17 37.78 p = 0.011
Endothelin-1 ≥ 2.5 pg/mL 13 61.19 31 68.89 NS
Bold: p < 0.05.
Table 8. Concentrations of the selected endothelial dysfunction markers and lipid metabolism
parameters in the patients with RP in relation to age.
Biochemical Parameters
Age ≤ 15 Years
n = 13
Age >15 Years
n = 53 Chi-Square Test
n % n %
Total cholesterol > 180 mg/dL 2 15.38 6 11.32 NS
LDL cholesterol > 115 mg/dL 1 7.69 29 54.72 p = 0.002
HDL cholesterol ≤ 48 mg/dL 3 23.08 39 73.58 p < 0.001
Triglycerides > 110 mg/dL 1 7.69 22 41.51 p = 0.022
E - selectin ≥ 40 ng/mL 7 53.85 25 47.17 NS
Endothelin ≥ 2.5 pg/mL 5 38.46 39 73.58 p = 0.016
hsCRP≥ 0.5 mg/dL 3 23.08 30 56.60 p = 0.030
Bold: p < 0.05.
On the other hand, when comparing the concentrations of the analyzed biomarkers between both
RP groups, a statistically significant difference was found only in respect of sE-selectin concentration
(Figure 4). The analysis of the lipid profile revealed a significantly lower HDL fraction concentration in
RP patients compared with the control group (p < 0.001). The remaining lipid parameters were not
differing significantly between the study groups.
The U-Mann–Whitney test were used to compare the following groups: uRP (n = 34), sRP
(n = 32), control group (n = 20). While comparing the groups, the results of endothelin-1 and sE-selectin
measurements were taken into consideration: Endothelin-1 concentration in the uRP group (median = 3.46,
Q25 = 2.34, Q75 = 4.41), endothelin-1 concentration in the sRP group (median = 2.97, Q25 = 2.105,
Q75 = 4.385), endothelin-1 concentration in the control group (median = 1.93, Q25 = 1.22, Q75 = 3.01),
sE-Selectin concentration in the uRP group (median = 35.92, Q25 = 31.2, Q75 = 42.25), sE-selectin
concentration in the sRP group (median = 44.15, Q25 = 37.46, Q75 = 58.34), sE-selectin concentration in
the control group (median = 22.315, Q25 = 17.225, Q75 = 28.295).
The analysis of multiple linear regression demonstrated that megacapillaries were the
capillaroscopic parameters most strongly determining the sE-selectin value (Table 9).
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Table 9. Factors (capillaroscopic parameters) determining sE-selectin concentration in the study group
(determination coefficient R2 = 0.21).
Variable BETA Standard Error BETA p
Reduced number of capillaries (<6/mm) 0.45 0.25 0.08
Irregular arrangement 0.03 0.21 0.88
Tortuous capillaries −0.06 0.15 0.71
Meandering capillaries 0.00 0.14 0.99
Presence of avascular areas 0.09 0.15 0.52
Giant capillaries/microhemorrhages 0.29 0.14 0.04
Spastic capillaries −0.11 0.13 0.37
Neoangiogenesis −0.08 0.13 0.55
Bold: p < 0.05.
On the other hand, the presence of avascular areas and microhemorrhages were the capillaroscopic
parameters most strongly determining the hsCRP value in the group with Raynaud’s phenomenon in
multiple regression analysis (Table 10).
Table 10. Factors (capillaroscopic parameters) determining high-sensitivity c-reactive protein (hsCRP)
concentration in the study group (determination coefficient R2 = 0.25).
Variable BETA Standard Error BETA p
Reduced number of capillaries (<6/mm) 0.45 0.25 0.08
Irregular pattern 0.04 0.17 0.81
Tortuous capillaries −0.08 0.16 0.64
Meandering capillaries 0.29 0.16 0.07
Giant capillaries/microhemorrhages 0.20 0.13 0.03
Presence of avascular areas 0.32 0.14 0.03
Spastic capillaries −0.11 0.13 0.37
Neoangiogenesis −0.08 0.13 0.55
Bold: p < 0.05.
None of the analyzed capillaroscopic parameters exerted any significant effect on the endothelin value.
On the other hand, multiple regression analysis of biochemical parameters shown a significant
correlation between hsCRP and endothelin-1 (R2 = 0.25, β = 0.31, p = 0.049).
Lipid metabolism parameters were also assessed. Both the total cholesterol and LDL fraction
concentrations were determined by the presence of avascular areas: R2 = 0.23, β = 0.34, p = 0.02,
R2 = 0.19, β = 0.36, p = 0.02, respectively.
4. Discussion
In the opinion of some authors, the abnormal capillaroscopic pattern can be seen in healthy children
in as much as 15–37% of cases [30,31]. In our studies, the abnormal capillaroscopic results in the control
group concerned only the presence of tortuous capillaries (35%), meandering capillaries (20%) and
spastic loops (24%). It should also be stressed that in the control group no vessel reduction, avascular
areas or megacapillaries were found on NVC. Other researchers also revealed no capillaroscopic images
of scleroderma pattern in their control group [5,27,30].
Ingegnoli and Herrick, based on the review of many studies, found that the capillaroscopic image of
the nail shaft does not differ in healthy boys and girls. The tendency to increase the density of capillaries
with age and is part of the maturation process, while the number of non-specific abnormalities in the
vascular loop image increases with age [32,33]. The results of our research in adolescents with RP over
15 years, showed significantly more frequent abnormalities of the microcirculation architecture in NVC
(irregular arrangement, tortuous and meandering capillaries, respectively: p = 0.014, p = 022, p = 0.005)
compared to the group of subjects under 15 years.
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In general, the analysis of capillaroscopic parameters comparing males and females did not show
significant differences in the microcirculation architecture. The significantly higher presence of giant
capillaries (p = 0.017) in female patients can be explained by an increased proportion of sRP compared
to the male gender (females-65.7% versus males-34.3%)
Concerning absence of established common terminology of capillaroscopic patterns in children
and adolescents and limited data on among this age group, these finding can be interesting both for
further research as well as practical application in pediatric rheumatologists’ practice.
A very interesting result of our research is the finding of significantly more frequent "scleroderma
pattern" images in NVC in the patients with the RP. Our studies revealed a significantly more frequent
occurrence of giant capillaries (p = 0.008), microhemorrhages (p = 0.031) and significantly reduced
number of capillaries in the patients with Raynaud’s syndrome compared to healthy children in the
control group (p = 0.015), which may indicate a subclinical process of vasculitis and the threat of
organ-related complications, even in CTDs with low inflammatory activity.
It should be emphasized that the abnormal capillaroscopic results were more frequent significantly
different in patients with sRP than uRP compared to the control group.
No significant differences were found concerning the presence of tortuous capillaries and spastic
loops compared to the control group.
Studies of the adult population suggest that the presence of an abnormal image of the “scleroderma
pattern” is a predictor of CTD in the future, despite the absence of clinical symptoms at the time of the
study [34]. However, similar reports on children and adolescents are very limited [30,35]. In clinical
practice, making a diagnosis in young patients with the Raynaud syndrome is difficult, hence the
need to regularly repeat NVC in this group of patients. This is also related to the fact that the image
of the vascular loops in patients with the secondary symptom of Raynaud sRP can undergo rapid
progression. According to reports, even 15–20% of patients with the "scleroderma pattern" developed
connective tissue diseases in 2–10 years, although initially, they did not meet Raynaud’s criteria [31,36].
The relationship between structural capillaroscopic abnormalities and endothelial dysfunction
biomarkers seems interesting, although poorly elucidated.
The relationship between morphological abnormalities of capillaries, biomarkers of activation
and inflammatory endothelial dysfunction in autoimmune diseases occurring with or without RP is
interesting, though little understood, [1,32,37]. Activation of the endothelium is the first response
of the vascular wall to mechanical factors (including disturbed flow), chemical (hypoxia, increased
concentration of oxygen free radicals), biochemical (an increase of LDL concentration, cytokines) or
biological (including antibodies). Regardless of the type of endothelial damage factors, the consequence
is vasoconstriction associated with the release of Endothelin -1 in the first place [38,39].
The studies of endothelin-1 in RP patients conducted as yet, concerned its participation in the
pathomechanism of RP. It has been demonstrated that its secretion is stimulated by low temperature,
pressure increase or vascular wall stretching, angiotensin II, interleukin 1 (IL-1) and hypoxia [15,38].
A significant relationship between the presence of microangiopathy on NVC and higher serum
ET-1 levels was demonstrated in Raynaud’s phenomenon both in children [26] and adults [40,41].
This is confirmed by the results of our studies in which serum ET-1 concentration was significantly
higher in both uRP and sRP compared to the control group (p = 0.0134). Moreover, the higher ET-1
concentration in the sRP group compared to uRP, although not statistically significant, suggests its
relationship with the degree of microvascular damage, and thus indirectly with endothelial dysfunction.
An interesting result in the same regression model as above is finding a significant relationship between
hsCRP and endothelin-1 (R2 = 0.25, p = 0.049).
Therefore, our results suggest the participation of endothelin-1 in the pathomechanism of
RP but also its possible proinflammatory effect and endothelial activation. Proinflammatory and
immunomodulating effects ET-1 on endothelium are confirmed by the results of research in other
diseases [42].
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Another parameter arousing interest as an endothelial dysfunction marker is sE-selectin. It is expressed
on activated endothelial cells due to the effect of proinflammatory cytokines, and the current theory
of atherosclerosis development ascribes to it an important role at the earliest stage of atheromatous
plaque formation [43,44] At the same time, sE-selectin participation in the pathogenesis of Raynaud’s
phenomenon is taken into account, since an increased sE-selectin expression is observed on the
endothelial cells in the group of patients with Raynaud’s phenomenon, in whom SSc developed [12,45].
The results of our studies show a significantly higher sE-selectin concentration in the group of
patients with secondary Raynaud’s phenomenon, in which “scleroderma pattern” of capillaries
predominate. The relationship between abnormal capillaroscopic parameters and possible endothelial
dysfunction was suggested by the analysis of multifactorial linear regression, which demonstrated
that megacapillaries and microhemorrhages on capillaroscopy examination were the parameters most
strongly determining the sE-selectin concentration in the whole study group (R2 = 0.21, p = 0.04).
These results are in concordance with the study by Valentini G et al., who demonstrated a
higher prevalence of digital ulcers and increased serum levels of soluble E-selectin in RP patients,
who had capillaroscopic “scleroderma pattern” on NVC, regardless of marker autoantibodies [46].
The researchers also connect the presence of the markers of inflammatory cell activation in patients
demonstrating abnormalities on NVC with preclinical cardiopulmonary alterations [34,47]. Yamane et al.
have found that soluble E-selectin concentration was significantly higher in patients with scleroderma
and was positively correlated with the size of skin lesions and the extent of areas involved [48].
Luskiewicz-Potemska et al. demonstrated a significantly higher serum sE-selectin level in children and
adolescents with RP and microangiopathy on NVC compared with those without microangiopathic
complications with normal NVC pattern, which also can suggest subclinical vasculitis [26].
It should be emphasized that only children and adolescents with RP with abnormal capillaroscopic
patterns (non-specific or scleroderma pattern) and low values of inflammatory process parameters,
in whom the history is taken and clinical examination ruled out the classic cardiovascular disease risk
factors, were qualified for the study presented, aimed at assessing microangiopathy with possible
damage to the endothelial function.
Thus, it seemed interesting to answer the question whether microangiopathy in the studied
patients is accompanied by the so-called low-grade inflammatory state, the recognized parameter of
which is the hsCRP protein.
Nielen et al. presented an interesting analysis of a group of patients, blood donors, in whom they
determined CRP level before rheumatoid arthritis (RA) development. They observed a higher CRP
level in that group, even before the appearance of disease manifestations, compared with the control
group [49]. The studies by other authors confirmed the importance of hsCRP in the development
of the first cardiovascular episode [22,50,51]. Attention has also been paid to the participation of
CRP in the inflammation accompanying atherosclerosis, which is related to its effect activating the
endothelial cells to express adhesion molecules (soluble intercellular adhesion molecule 1 - ICAM-1,
vascular cell adhesion molecule 1—VCAM-1, and E-selectin) [51–54]. In our studies, serum CRP
concentration determined by high sensitivity method (hsCRP) was a strong determinant of the presence
of avascular areas (R2 = 0.25, p = 0.03), giant and hemorrhages (p = 0.03). It seems very likely that the
consequences of even a low-grade inflammatory state of peripheral microcirculation vessels include
both functional and structural microangiopathy, which has been proven in the studies on children with
other diseases [37,49].
The literature data and previous own studies also showed higher hsCRP concentration in
secondary RP compared to primary RP, which may be associated with subclinical vasculitis and
possible endothelial dysfunction [54,55]
It suggests a relationship between elevated CRP concentrations and the presence of abnormal
capillaroscopic patterns in the aspect of subclinical microcirculatory inflammation process in patients
with long-lasting RP [53].
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Therefore, the importance of biochemical markers of endothelial injury and hsCRP in patients
with long-term Raynaud’s syndrome and capillary microscopic features of microangiopathy can be
considered in the context of precocious preclinical atherosclerosis [56]. Studies on the population
of adult patients with CTD with or without RP clearly indicate an increased risk of cardiovascular
disease in comparison to the healthy population [22,23,57]. In light of current knowledge, endothelial
dysfunction is the key and the earliest factor, both for immunological vasculitis and atherosclerosis [58].
It seems, therefore, that microangiopathy of the "scleroderma pattern" present in the capillaroscopic
examination in patients with Raynaud’s syndrome may be the result of endothelial damage—a common
link connecting subclinical vasculitis and atherosclerosis. Undoubtedly, the impact on the risk of
premature atherosclerosis in patients with CTDs has an atherogenic lipid profile, characterized by an
increase in LDL, and triglycerides, and HDL reduction [51]. In our study, we found a higher total
cholesterol concentration in both RP groups and a significantly lower concentration of HDL-cholesterol
compared to the control group (p = 0.001). Researchers suggest that the anti-inflammatory/protective
role of HDL may be in part related to their inhibitory effect on the expression of endothelial adhesion
particles [51]. On the other hand, in the multivariate regression analysis, both the total cholesterol and
LDL were determined by the presence of avascular areas. Because avascular fields are a "scleroderma
pattern" image, they can indirectly indicate damage to the vascular endothelium. It has been proven that
endothelial dysfunction is associated with increased permeability of the vascular wall to lipoproteins
already at the early stage of atherosclerosis [59].
In summary, despite the limitations of interpretation of the results of our studies, NVC should
be regarded as a useful microcirculatory diagnostic method not only in the context of CTDs with or
without RP, but also in less typical indications, particularly in vascular diseases.
In combination with the determination of biomarker of endothelial dysfunction, NVC may be
considered as a putative marker for subclinical vasculitis and endothelial dysfunction as well as a
candidate for a surrogate marker of preclinical stage of atherosclerosis. This, however, requires further
extended studies.
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